Carolina L. C.
- Country
- Spain
- Department
- Intensive Care Department
Research Overview
- Evaluation of AON-D21 Efficacy and Safety in Severe Community-Acquired Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Trial
- A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with severe community-acquired pneumonia (sCAP)
Data & Insights
Has run more than one trial at 9 of 69 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in the treatment of severe community-acquired pneumonia (sCAP), with particular focus on intensive care cases and advanced therapeutic interventions.
- Critical respiratory infections
- Intensive care management
- Advanced pneumonia treatments
The investigator's work centers on evaluating novel therapeutic approaches for patients requiring intensive care support.
Critical Care Medicine
With expertise in managing severe respiratory conditions in intensive care settings, the investigator explores innovative treatment modalities for critically ill patients.
- ICU patient care
- Severe infection management
- Critical care interventions
Their clinical focus includes assessment of new therapeutic agents for severe respiratory infections in hospitalized patients.
Therapeutic Development
The investigator evaluates novel immunological treatments for severe respiratory infections, including assessment of emerging therapeutic compounds.
- Immunological therapies
- Treatment efficacy evaluation
- Safety assessment protocols
Their work encompasses the evaluation of mortality outcomes and treatment effectiveness in severe pneumonia cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.